174 related articles for article (PubMed ID: 36982172)
1. An 8q24 Gain in Pancreatic Juice Is a Candidate Biomarker for the Detection of Pancreatic Cancer.
Levink IJM; Srebniak MI; De Valk WG; van Veghel-Plandsoen MM; Wagner A; Cahen DL; Fuhler GM; Bruno MJ
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982172
[TBL] [Abstract][Full Text] [Related]
2. Mutation Analysis of Pancreatic Juice and Plasma for the Detection of Pancreatic Cancer.
Levink IJM; Jansen MPHM; Azmani Z; van IJcken W; van Marion R; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685923
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma.
Nesteruk K; Levink IJM; de Vries E; Visser IJ; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
Pancreatology; 2022 Jun; 22(5):626-635. PubMed ID: 35613957
[TBL] [Abstract][Full Text] [Related]
4. Protein biomarkers in pancreatic juice and serum for identification of pancreatic cancer.
Levink IJM; Visser IJ; Koopmann BDM; van Driel LMJW; Poley JW; Cahen DL; Bruno MJ; Fuhler GM
Gastrointest Endosc; 2022 Nov; 96(5):801-813.e2. PubMed ID: 35537661
[TBL] [Abstract][Full Text] [Related]
5. Size and Concentration of Extracellular Vesicles in Pancreatic Juice From Patients With Pancreatic Ductal Adenocarcinoma.
Nesteruk K; Levink IJM; Dits NFJ; Cahen DL; Peppelenbosch MP; Bruno MJ; Fuhler GM
Clin Transl Gastroenterol; 2022 Feb; 13(3):e00465. PubMed ID: 35363220
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Copy-Number Alteration Analysis in Plasma Cell-Free DNA of Neuroendocrine Neoplasms is a Novel Specific Biomarker for Diagnosis, Prognosis, and Follow-up.
Boons G; Vandamme T; Mariën L; Lybaert W; Roeyen G; Rondou T; Papadimitriou K; Janssens K; Op de Beeck B; Simoens M; Demey W; Dero I; Van Camp G; Peeters M; Op de Beeck K
Clin Cancer Res; 2022 Jan; 28(2):338-349. PubMed ID: 34759042
[TBL] [Abstract][Full Text] [Related]
7. Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts.
Kanda M; Knight S; Topazian M; Syngal S; Farrell J; Lee J; Kamel I; Lennon AM; Borges M; Young A; Fujiwara S; Seike J; Eshleman J; Hruban RH; Canto MI; Goggins M
Gut; 2013 Jul; 62(7):1024-33. PubMed ID: 22859495
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic Juice Mutation Concentrations Can Help Predict the Grade of Dysplasia in Patients Undergoing Pancreatic Surveillance.
Suenaga M; Yu J; Shindo K; Tamura K; Almario JA; Zaykoski C; Witmer PD; Fesharakizadeh S; Borges M; Lennon AM; Shin EJ; Canto MI; Goggins M
Clin Cancer Res; 2018 Jun; 24(12):2963-2974. PubMed ID: 29301828
[No Abstract] [Full Text] [Related]
9. The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples.
Van Paemel R; Vandeputte C; Raman L; Van Thorre J; Willems L; Van Dorpe J; Van Der Linden M; De Wilde J; De Koker A; Menten B; Devalck C; Vicha A; Grega M; Schleiermacher G; Iddir Y; Chicard M; van Zogchel L; Stutterheim J; Lak NSM; Tytgat GAM; Laureys G; Speleman F; De Wilde B; Lammens T; De Preter K; Van Roy N
Eur J Cancer; 2022 Jan; 160():12-23. PubMed ID: 34794856
[TBL] [Abstract][Full Text] [Related]
10. Genomic analysis of pancreatic juice DNA assesses malignant risk of intraductal papillary mucinous neoplasm of pancreas.
Mateos RN; Nakagawa H; Hirono S; Takano S; Fukasawa M; Yanagisawa A; Yasukawa S; Maejima K; Oku-Sasaki A; Nakano K; Dutta M; Tanaka H; Miyano S; Enomoto N; Yamaue H; Nakai K; Fujita M
Cancer Med; 2019 Aug; 8(10):4565-4573. PubMed ID: 31225717
[TBL] [Abstract][Full Text] [Related]
11. Optimization of Pancreatic Juice Collection: A First Step Toward Biomarker Discovery and Early Detection of Pancreatic Cancer.
Levink IJM; Nesteruk K; Visser DI; Sieuwerts AM; Fernandes CJC; Jansen MPHM; van Driel LMJW; Poley JW; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
Am J Gastroenterol; 2020 Dec; 115(12):2103-2108. PubMed ID: 33105193
[TBL] [Abstract][Full Text] [Related]
12. Urothelial Carcinoma Detection Based on Copy Number Profiles of Urinary Cell-Free DNA by Shallow Whole-Genome Sequencing.
Ge G; Peng D; Guan B; Zhou Y; Gong Y; Shi Y; Hao X; Xu Z; Qi J; Lu H; Zhang X; Zhan Y; Li Y; Wu Y; Ding G; Shen Q; He Q; Li X; Zhou L; Ci W
Clin Chem; 2020 Jan; 66(1):188-198. PubMed ID: 31811000
[TBL] [Abstract][Full Text] [Related]
13. Digital PCR-based plasma cell-free DNA mutation analysis for early-stage pancreatic tumor diagnosis and surveillance.
Okada T; Mizukami Y; Ono Y; Sato H; Hayashi A; Kawabata H; Koizumi K; Masuda S; Teshima S; Takahashi K; Katanuma A; Omori Y; Iwano H; Yamada M; Yokochi T; Asahara S; Kawakubo K; Kuwatani M; Sakamoto N; Enomoto K; Goto T; Sasajima J; Fujiya M; Ueda J; Matsumoto S; Taniue K; Sugitani A; Karasaki H; Okumura T
J Gastroenterol; 2020 Dec; 55(12):1183-1193. PubMed ID: 32939577
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity in pancreatic juice differentiates pancreatic cancer from chronic pancreatitis: A meta-analysis.
Hata T; Ishida M; Motoi F; Yamaguchi T; Naitoh T; Katayose Y; Egawa S; Unno M
Pancreatology; 2016; 16(3):372-81. PubMed ID: 26899542
[TBL] [Abstract][Full Text] [Related]
15. Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms.
Yu J; Sadakari Y; Shindo K; Suenaga M; Brant A; Almario JAN; Borges M; Barkley T; Fesharakizadeh S; Ford M; Hruban RH; Shin EJ; Lennon AM; Canto MI; Goggins M
Gut; 2017 Sep; 66(9):1677-1687. PubMed ID: 27432539
[TBL] [Abstract][Full Text] [Related]
16. Multiple-level copy number variations in cell-free DNA for prognostic prediction of HCC with radical treatments.
Wang Y; Zhou K; Wang X; Liu Y; Guo D; Bian Z; Su L; Liu K; Gu X; Guo X; Wang L; Zhang H; Tao K; Xing J
Cancer Sci; 2021 Nov; 112(11):4772-4784. PubMed ID: 34490703
[TBL] [Abstract][Full Text] [Related]
17. [Mutation of the K-ras oncogene in pancreatic carcinoma, and application of its detection in pancreatic juice to diagnose pancreatic carcinoma].
Sawabu N; Watanabe H; Yamaguchi Y; Okai T
Nihon Rinsho; 1995 Feb; 53(2):511-7. PubMed ID: 7699881
[TBL] [Abstract][Full Text] [Related]
18. Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancer.
Liu X; Liu L; Ji Y; Li C; Wei T; Yang X; Zhang Y; Cai X; Gao Y; Xu W; Rao S; Jin D; Lou W; Qiu Z; Wang X
EBioMedicine; 2019 Mar; 41():345-356. PubMed ID: 30857943
[TBL] [Abstract][Full Text] [Related]
19. Precision oncology: Artificial intelligence, circulating cell-free DNA, and the minimally invasive detection of pancreatic cancer-A pilot study.
Bahado-Singh RO; Turkoglu O; Aydas B; Vishweswaraiah S
Cancer Med; 2023 Oct; 12(19):19644-19655. PubMed ID: 37787018
[TBL] [Abstract][Full Text] [Related]
20. Cell-Free DNA From Metastatic Pancreatic Neuroendocrine Tumor Patients Contains Tumor-Specific Mutations and Copy Number Variations.
Boons G; Vandamme T; Peeters M; Beyens M; Driessen A; Janssens K; Zwaenepoel K; Roeyen G; Van Camp G; Op de Beeck K
Front Oncol; 2018; 8():467. PubMed ID: 30443491
[No Abstract] [Full Text] [Related]
[Next] [New Search]
